This brief highlights how genetic factors may interact with diet to influence cognitive trajectories in older adults. The finding that meat consumption could be associated with slower cognitive decline in individuals with high-risk APOE variants underscores the importance of considering individualized risk profiles when discussing brain health, rather than applying blanket dietary recommendations. For psychotherapists, social workers, and other mental health clinicians, the study illustrates the potential relevance of lifestyle factors as moderators of cognitive aging in client populations, suggesting attention to personalized risk factors in holistic wellbeing plans.

Article Title: Eating more meat may lower Alzheimer’s risk for some people

Link to Science Daily Mind-Brain News: https://www dot sciencedaily dot com/releases/2026/04/260401071931 dot htm

Eating more meat may lower Alzheimer’s risk for some people
https://www dot sciencedaily dot com/releases/2026/04/260401071931 dot htm
A surprising new study suggests that genetics may change how diet affects brain health—especially when it comes to Alzheimer’s risk. Researchers found that older adults carrying high-risk APOE gene variants didn’t show the expected cognitive decline if they ate relatively high amounts of meat. In fact, those with these genes who consumed the most meat had slower cognitive decline and lower dementia risk, challenging conventional dietary advice.
via Mind & Brain News -- ScienceDaily https://www dot sciencedaily dot com/news/mind_brain/
April 2, 2026 at 09:49AM

#alzheimers #diet # APOE #cognitivehealth #geriatricmedicine

Copy and paste broken link above into your browser and replace "dot" with "." for link to work.

We have to do it this way to avoid display of copyrighted images.

Healing Belongs at Home – Dr. Charu Dutt Arora’s Powerful TEDx Greenfield Talk - Asian Talks

Among these voices was Dr. Charu Dutt Arora, Consultant Physician in Geriatrics, Palliative Care, and Infectious Diseases at AmeriHealth, Asian Hospital,

Asian Talks
Healing Belongs at Home – Dr. Charu Dutt Arora’s Powerful TEDx Greenfield Talk – Tycoon World

Among these voices was Dr. Charu Dutt Arora, Consultant Physician in Geriatrics, Palliative Care, and Infectious Diseases at AmeriHealth, Asian Hospital,

Tycoon World

'Outcomes of endovascular treatment in nonagenarians with symptomatic peripheral arterial disease' - a Hogrefe #Medicine article on #ScienceOpen:

🔗 https://www.scienceopen.com/document?vid=d29d1fef-b3ae-46c1-804c-57f076ebbe50

#VascularMedicine #GeriatricMedicine #PeripheralArterialDisease

Outcomes of endovascular treatment in nonagenarians with symptomatic peripheral arterial disease

<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d10776790e72"> Summary: Background: To report the clinical outcomes of endovascular therapy in nonagenarians treated for symptomatic peripheral arterial disease (PAD). Patients and methods: This is a retrospective analysis of 81 nonagenarians (mean age 93±2.4 years) treated by endovascular therapy for chronic limb threatening ischemia (CLTI) or claudication between December 2017 and August 2023. The composite of amputation and/or death (amputation-free survival; AFS) was the primary endpoint. Technical success, mortality, major limb amputation, risk for Major Adverse Cardio-Cerebro-vascular Events (MACCE) and re-intervention during follow-up were additionally analysed. Results: Most patients presented with CLTI (n=75, 93%). Popliteal artery interventions were most frequently performed (n=59, 73%), followed by superficial femoral artery (n=57, 70%), tibial (n=49, 61%), aortoiliac (n=11, 14%) and common femoral artery (n=7, 9%) procedures. The technical success rate was 100% and the in-hospital mortality was 1% (n=1). At 24 months the AFS was 23.5%, while the major amputation and mortality rates were 4.9% and 75.3% respectively. In the same period the rate of MACCE was 74.1% and the freedom from re-intervention rate amounted to 85.2% The cox regression analysis revealed a lower AFS among males (HR:1.8, 95% CI: 1.06–3.03, p=0.03) and a higher risk for MACCE in patients on warfarin (HR:3.1, 95% CI:1.26–7.59, p=0.01). Conclusions: Despite the high technical success and the low amputation rates, a very high mortality rate at follow up was observed among nonagenarians undergoing endovascular procedures for PAD. Male gender and Warfarin administration increased the risk for adverse events. </p>

ScienceOpen

Could Getting Rid of Old Cells Turn Back the Clock on Aging?
Researchers are investigating medicines that selectively kill decrepit cells.

https://arstechnica.com/science/2022/12/could-getting-rid-of-old-cells-turn-back-the-clock-on-aging/

#cellularBiology #aging #scientificresearch #geriatricmedicine

Could getting rid of old cells turn back the clock on aging?

Researchers are investigating medicines that selectively kill decrepit cells.

Ars Technica

https://www.nytimes.com/explain/2022/11/20/health/medicare-open-enrollment?smid=nytcore-ios-share&referringSource=articleShare

This is a nice breakdown of some differences between traditional Medicare, Medicare Advantage, and Medigap plans. It doesn’t go into what kind of crazy profits are made off of denying care.

#MedMastodon #Medicare #Insurance #MedTwitter #HealthCareCost #MedicareForAll #HealthCareIsAHumanRight #GeriatricMedicine